Fig. 3
From: Nomogram predicts risk of perineural invasion based on serum biomarkers for pancreatic cancer
(A-B) the AUC value of the nomogram prediction in the training and validation cohorts. (C) Boxplot of probability of PNI (%) between the high-risk and low-risk in the training and validation cohorts. (D-E) Decision curve analysis showed clinical benefits of the model predicting PNI compare to the single indicators (CA19-9, total bilirubin, and blood glucose) in the training and validation cohorts